Asia's Outbreaks Risk Renewed Infection, Economic Stagnation
Investors should watch Asian vaccination rates for a guide to the continent's economic rebound.
A Peek at Peaking GDP, Amazon Riptide, Message for Anti-Vaxxers, Cliffs Note
Plus, we take a deeper dive into the second-quarter GDP numbers.
Jim Cramer: Take It From a Guy Who Knows, the IPO Process Is Really Flawed
As the Robinhood debacle shows, not much has changed over the decades when it comes to initial public offerings.
When American Woodmark Gets Sawed Down, I Buy
Here's a case study in how sometimes when a stock you own plunges on no real bad news, you should stock up.
Will an Amazon Selloff Trigger Better Rotational Action?
The big question is whether everything will be dragged down together or whether there will be some tradable rotation.
So Many Excuses for the Mega Caps
Let's see how in July complacency has returned in full force when it comes to these super stocks.
A Healthy Outlook for Merck and Its Organon Spinoff
Organon's management team has deep leadership, operating and financial experience.
Albemarle Continues to Make New Highs
Here's our latest look at the specialty chemical company's charts.
Indexes Close Up but Trading's Muted
The action wasn't poor, but Amazon takes a hit and momentum slows.
Jim Cramer: The Biggest Thing That Happened Thursday Was the Boring Stuff
No, it wasn't Robinhood or the mega-cap tech companies, it was names we depend on like Carrier Global.